[Glucagon peptide--new treatment for late-onset diabetes?].
Koivisto
V
V
D002096:C-Peptide / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005768:Gastrointestinal Hormones / Q000627:therapeutic use*; D005934:Glucagon / Q000276:immunology*; D004763:Glucagon-Like Peptides; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D010187:Pancreatic Hormones / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use*; D011498:Protein Precursors / Q000627:therapeutic use
D002096:C-Peptide; D005768:Gastrointestinal Hormones; D007004:Hypoglycemic Agents; D007328:Insulin; D010187:Pancreatic Hormones; D010455:Peptides; D011498:Protein Precursors; D004763:Glucagon-Like Peptides; C015236:glucagon-like-immunoreactivity; D005934:Glucagon